JASUF yields 8000.00% · PFE yields 6.13%● Live data
📍 JASUF pulled ahead of the other in Year 1
Combined, JASUF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of JASUF + PFE for your $10,000?
Jasmine International Public Company Limited provides telecommunications services to individual and corporate clients in Thailand. The company provides high-speed connectivity; Internet services and applications; and software development, distribution, and general software services, including software system that supports value added services for broadband Internet business. It also offers marine and submarine optical fiber maintenance services; international private leased-circuit, Internet protocol virtual private network services, leased line Internet services, managed network services through optic fiber and copper cable networks, National Internet Exchange services, and co-location services and satellite communications. In addition, the company provides data center services; online movie and internet protocol television services; fixed-line services; international calling cards services; wireless communication services through very small aperture terminal; satellite phone services, and small mobile handset and fixed handset for users to use the service from a fixed indoor location in a remote area; and distributes equipment. Further, it engages in system integration, equipment sourcing, system design, and IT systems implementation for government and private sectors; cloud computing; the consultancy, design, and implementation of computer and IT network systems; the provision of space rental services; and investing in telecommunications infrastructure business, other assets, securities, and/or instruments. The company was founded in 1982 and is headquartered in Nonthaburi, Thailand.
Full JASUF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.